The Study of Abatacept in Combination With Etanercept

Bristol-Myers Squibb (BMS)

Status and phase: Completed; Phase 2

Conditions: Rheumatoid Arthritis

Treatments: Drug: Abatacept

Study type: Interventional

Funder types: Industry

Identifiers

NCT00162279

IM101-101

Details and patient eligibility

About

The Study was designed to look at the safety and efficacy of abatacept in combination with etanercept.

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• All subjects who had completed the short term portion of IM101-101.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Single Group Assignment

Masking: Double Blind